Filing Details
- Accession Number:
- 0001104659-25-051980
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-22 16:05:17
- Reporting Period:
- 2025-05-22
- Filing Date:
- 2025-05-22
- Accepted Time:
- 2025-05-22 16:05:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1390478 | Sellas Life Sciences Group Inc. | SLS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1832671 | Bach Katherine Kalin | C/O Sellas Life Sciences Group, Inc., 7 Times Square, Suite 2503 New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-22 | 20,000 | $1.80 | 41,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
